Source: Cancer Chemotherapy and Pharmacology. Unidades: FCF, FM
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), MIELOMA MÚLTIPLO, QUIMIOTERAPIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUNGRIA, Vania Tietsche de Moraes et al. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, v. 53, n. 1, p. 51-60, 2004Tradução . . Disponível em: https://doi.org/10.1007/bf02665353. Acesso em: 30 set. 2024.APA
Hungria, V. T. de M., Latrilha, M. C., Rodrigues, D. G., Bydlowski, S. P., Chiattone, C. S., & Maranhão, R. C. (2004). Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, 53( 1), 51-60. doi:10.1007/bf02665353NLM
Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease [Internet]. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/bf02665353Vancouver
Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease [Internet]. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/bf02665353